Crenolanib (CP-868,596) Is a Potent and Selective Type I FLT3 Inhibitor That Retains Activity Against AC220 Resistance-Causing FLT3 Kinase Domain Mutants

Autor: Smith, Catherine C, Lasater, Elisabeth *, Mccreery, Melissa *, Lin, Kimberly *, Stewart, Whitney *, Damon, Lauren E *, Perl, Alexander E, Jeschke, Grace R *, Sugita, Mayumi, Carroll, Martin, Kogan, Scott C., Shah, Neil
Zdroj: In Blood 16 November 2012 120(21):141-141
Databáze: ScienceDirect